Photo by vita_belvita from unsplash
prescribed medicine and patient records. The endpoints height and bone mineral content, using dual- energy X- ray absorptiometry (DXA) scans, were assessed at age 6 years. The results showed a… Click to show full abstract
prescribed medicine and patient records. The endpoints height and bone mineral content, using dual- energy X- ray absorptiometry (DXA) scans, were assessed at age 6 years. The results showed a significant height reduction at age 6 years by 0.26 cm per 1- year stan- dard treatment compared with children with no treatment or a cumulative ICs dosage less than 10 weeks of standard treatment. This association was also found when analysing ICs use and height up to 3 years of age. However, the effect was limited to those with current treatment at the age of 6 years, while no significant association was found in those who had stopped
Journal Title: Thorax
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!